Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 06, 2026
Ondas Inc. (ONDS) Stock Holds Steady Amid Acquisitions and Defense Momentum

Ondas Inc. (ONDS) Stock Holds Steady Amid Acquisitions and Defense Momentum

Key Takeaways

  • Ondas Inc. (ONDS) shares have traded in a volatile range between roughly $6.50 and $8.24 over the past 30 days, reflecting mixed sentiment amid transformative acquisitions and a pullback from earlier 2026 highs.
  • The company closed its landmark $875 million acquisition of DZYNE Technologies in early July, significantly expanding its autonomous defense portfolio and prompting management to raise full-year 2026 revenue guidance to at least $525 million.
  • BlackRock disclosed a 7.2% stake in ONDS via an SEC filing, drawing attention from traders alongside persistently elevated short interest above 30%.
  • More than $70 million in new orders were announced during July 2026, spanning counter-UAS systems, autonomous ground vehicles, ISR platforms, and precision-strike capabilities.
  • Ondas is scheduled to report second-quarter 2026 financial results on August 13, 2026, which will offer updated insight into integration progress and revenue execution.

Current Market Snapshot

Ondas Inc. (ONDS) has experienced a choppy trading pattern in recent weeks, with the stock oscillating between approximately $6.50 and $8.24 per share throughout July 2026. The shares declined from $7.92 at the beginning of the month, reflecting a measured pullback of roughly 7% amid broader sector rotation and investor digestion of the company's aggressive acquisition strategy. Trading volume has been elevated, averaging well above historical norms, as institutional and retail participants reassess the company's rapidly expanding footprint across autonomous defense, counter-drone, and ISR technologies. With a market capitalization near $4 billion and a forward price-to-sales ratio hovering around 7.3, the stock continues to attract attention from growth-oriented investors and short sellers alike. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Ondas Inc. (ONDS) Business Overview and Competitive Position

Ondas Inc. is a provider of autonomous systems, robotics, and mission-critical technologies serving defense, homeland security, public safety, and critical infrastructure markets globally. The company develops and deploys integrated unmanned platforms across air, ground, and stratospheric environments — including autonomous drone systems, counter-UAS technologies, robotic ground vehicles, advanced aircraft and propulsion solutions, demining systems, and integrated sensing and communications technologies. Through its Ondas Sentinel division, formed following the acquisitions of World View and DZYNE Technologies, the company has consolidated a multi-domain autonomous defense platform designed to compete for large-scale government and military contracts. Ondas is also co-developing SkyWeaver, an AI-powered mission intelligence platform in partnership with Palantir Technologies, which aims to unify sensor data, autonomous platforms, and decision-making across a single operational environment. The company's strategic vision centers on becoming a scaled, end-to-end autonomous defense prime, leveraging serial acquisitions to build manufacturing capacity, engineering talent, and a contract pipeline exceeding $4.5 billion.

Recent Developments Driving ONDS

Several material developments have shaped investor sentiment around ONDS over the past 30 days. The most significant was the July 2 closing of the DZYNE Technologies acquisition, an $875 million transaction that added long-endurance ISR aircraft, kinetic counter-UAS interceptors, autonomous strike platforms, and approximately 145,000 square feet of U.S. manufacturing capacity. Management subsequently raised its 2026 revenue target to at least $525 million from a prior $390 million, reflecting contributions from DZYNE and the earlier Omnisys acquisition. In mid-July, the company announced more than $70 million in new orders secured over a four-week period, including a $6.9 million contract from the Australian Department of Defence for counter-drone systems. Additionally, an SEC filing revealed that BlackRock Inc. holds a 7.2% stake in Ondas, representing 38.1 million shares — a disclosure that intensified focus on the stock's elevated short interest, which has remained above 30% for more than five months. Needham lowered its price target to $19 from $23 while maintaining a Buy rating, citing the strengthened portfolio and path toward $1 billion in annual revenue by 2027. From what I see, the combination of institutional interest and fresh contracts adds another layer worth monitoring.

2026 Outlook and What Investors Should Watch

Looking ahead, the most immediate catalyst for ONDS is the second-quarter 2026 earnings report scheduled for August 13, which will provide the first detailed look at financial performance following the DZYNE integration. Investors will closely scrutinize top-line revenue progression, order backlog conversion, and progress toward management's $525 million full-year target. The expected third-quarter closing of the Cyberhawk acquisition, valued at $125 million, could further expand the company's pipeline and recurring revenue base, though it may also add integration complexity. On the macroeconomic front, global defense budgets continue to prioritize autonomous and counter-drone capabilities, providing a favorable demand backdrop. However, risks remain substantial: the company's aggressive M&A strategy has resulted in significant shareholder dilution, with shares outstanding roughly doubling over the past year, and the path to sustained GAAP profitability remains uncertain. Analysts project Ondas may achieve its first full year of GAAP profitability in 2026, but free cash flow could remain negative into 2029. Additionally, any slowdown in government contract awards, execution missteps during integration, or shifts in defense spending priorities could materially affect the stock's trajectory. I’m watching this closely as the earnings release approaches.

Exploring AI-Powered Trading Approaches

In my own research process, I’ve found value in reviewing Tickeron’s Trending AI Robots page when evaluating stocks in dynamic sectors like defense. It surfaces a selection of algorithmic bots with strong historical performance across various strategies and risk levels, helping to put broader market signals into context without replacing fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ONDS

ONDS in upward trend: price rose above 50-day moving average on August 04, 2026

ONDS moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend. In of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on ONDS as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ONDS just turned positive on July 21, 2026. Looking at past instances where ONDS's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONDS advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for ONDS moved below the 200-day moving average on July 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONDS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ONDS entered a downward trend on July 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONDS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.706) is normal, around the industry mean (6.913). P/E Ratio (98.556) is within average values for comparable stocks, (73.629). ONDS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.194). ONDS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (28.571) is also within normal values, averaging (14.461).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONDS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

Notable companies

The most notable companies in this group are Cisco Systems (NASDAQ:CSCO), Hewlett Packard Enterprise Company (NYSE:HPE), Lumentum Holdings (NASDAQ:LITE), Ciena Corp (NYSE:CIEN), Nokia Corp (NYSE:NOK), Ericsson (NASDAQ:ERIC).

Industry description

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

Market Cap

The average market capitalization across the Telecommunications Equipment Industry is 21.87B. The market cap for tickers in the group ranges from 1.59K to 478.88B. CSCO holds the highest valuation in this group at 478.88B. The lowest valued company is ABILF at 1.59K.

High and low price notable news

The average weekly price growth across all stocks in the Telecommunications Equipment Industry was 14%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 26%. AAOI experienced the highest price growth at 68%, while CLRO experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Telecommunications Equipment Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 55
Price Growth Rating: 47
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
ONDS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry TelecommunicationsEquipment

Profile
Details
Industry
N/A
Address
222 Lakeview Avenue
Phone
+1 888 350-9994
Employees
495
Web
https://www.ondas.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.